ResearcherPhilipps University of MarburgNo recent work listed

Uwe Schlomann

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5003031304. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2015: 1 paper

Papers 1

ADAM8 as a drug target in pancreatic cancer. Co-author DOI 10.1038/ncomms7175 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Rozita Roshani · 1 shared paper, 2015 · strength 0.04
- Paper ADAM8 as a drug target in pancreatic cancer. DOI 10.1038/ncomms7175 ↗
Miles Aaron Miller · 1 shared paper, 2015 · strength 0.04
- Paper ADAM8 as a drug target in pancreatic cancer. DOI 10.1038/ncomms7175 ↗
Thorsten Hagemann · 1 shared paper, 2015 · strength 0.04
- Paper ADAM8 as a drug target in pancreatic cancer. DOI 10.1038/ncomms7175 ↗
David Arthur Tuveson · 1 shared paper, 2015 · strength 0.04
- Paper ADAM8 as a drug target in pancreatic cancer. DOI 10.1038/ncomms7175 ↗
Jörg Walter Bartsch · 1 shared paper, 2015 · strength 0.04
- Paper ADAM8 as a drug target in pancreatic cancer. DOI 10.1038/ncomms7175 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.